Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dhoot
Anubhav Dhoot, Bothell, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090112559 | MODEL-DRIVEN, REPOSITORY-BASED APPLICATION MONITORING SYSTEM - Enabling and processing events. To enable events, an application model correlated to an application is declaratively defined. The application model describes operations of the application. One or more event models correlated to the application model are declaratively defined. The event models describe application execution locations where events are desired to be emitted in the execution of the application. Based on the correlation of the event models to the application models, the applications are instrumented with instrumentation code to cause the application to emit events at the execution locations. To process events an application model is defined. The application model includes one or more observation models. The observation models include a correlation of events to the observation model by defining instrumentation models in the application model. An event is received. The event is applied to the observation model based on the correlation. The event is processed according to the observation model. | 04-30-2009 |
| 20090113437 | TRANSLATING DECLARATIVE MODELS - The present invention extends to methods, systems, and computer program products for translating declarative models. Embodiments of the present invention facilitate processing declarative models to perform various operations on applications, such as, for example, application deployment, application updates, application control such as start and stop, application monitoring by instrumenting the applications to emit events, and so on. Declarative models of applications are processed and realized onto a target environment, after which they can be executed, controlled, and monitored. | 04-30-2009 |
Gurtej Kaur Dhoot, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110281803 | SULFATASE ENZYMES - An isolated polypeptide inhibitor of SuIfIa having a sequence which is a variant of Sulf1a, and which lacks sulfatase activity and lacks the ability to bind to the surface of a cell. The polypeptide inhibitor of SuIf1a may be the alternatively spliced isoform SuIf1b. An isolated polypeptide inhibitor of Sulf2a having a sequence which is a variant of Sulf2a, and which lacks sulfatase activity and lacks the ability to bind to the surface of a cell. The polypeptide inhibitor of Sulf2a may be the alternatively spliced isoform Sulf2b. A method of combating a cancer in which Wnt signalling is upregulated or of treating ischaemia in a patient, the method comprising administering to the patient a polypeptide inhibitor of Sulf1a and/or Sulf2a. A method of combating a cancer in which Wnt signalling is not upregulated, the method comprising administering to the patient an inhibitor of Sulf1b and/or Sulf2b. | 11-17-2011 |
Nikhil Dhoot, Dombivli (east) IN
| Patent application number | Description | Published |
|---|---|---|
| 20080269108 | Crystalline forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid - The present invention relates to crystalline polymorphic forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, pharmaceutical compositions containing the same, methods of preparing the same, and methods for facilitating the delivery of active agents with the same. | 10-30-2008 |
| 20100055194 | PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT - This invention relates to microparticles and/or nanoparticles containing a delivery agent and/or an active agent. This invention also relates to pharmaceutical formulations and solid dosage forms, including controlled release solid dosage forms of active agent and a delivery agent. | 03-04-2010 |
Nikhil Dhoot, Wappingers Falls, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080279783 | ISOLATED NANOCAPSULE POPULATIONS AND SURFACTANT-STABILIZED MICROCAPSULES AND NANOCAPSULES FOR DIAGNOSTIC IMAGING AND DRUG DELIVERY AND METHODS FOR THEIR PRODUCTION - A method for producing surfactant-stabilized microcapsules or nanocapsules including the steps of (a) preparing a suspension comprising a non-ionic sorbitan detergent and a salt in phosphate buffered saline; (b) adding to the suspension a nonionic polyoxyethylenesorbitan detergent to produce a solution; (c) heating while stirring the solution of step (b) to 55±5° C. and maintaining the temperature of the solution at 55±5° C. for several minutes; (d) allowing the solution to cool to room temperature; (e) autoclaving the solution; (f) creating surfactant-stabilized microbubbles and nanobubbles in the solution; and (g) collecting surfactant-stabilized nanocapsules and microcapsules formed from the microbubbles and nanobubbles. | 11-13-2008 |